MRUS - Merus nabs US Orphan Drug tag for Zeno in pancreatic cancer July, 27 2020 11:40 AM Merus N.V. The FDA has designated Orphan Drug status for Merus's (MRUS -0.9%) Zenocutuzumab (Zeno) for the treatment of pancreatic cancer.More news on: Merus N.V., Healthcare stocks news, Read more ...